Rob Stein

Rob Stein appears in the following:

The FDA is reviewing COVID vaccines for children 5 and younger

Tuesday, June 14, 2022

Food and Drug Administration advisers are opening a two-day meeting to review Moderna and Pfizer-BioNTech's COVID-19 vaccines for children, including the first vaccines for kids younger than age 5.

Comment

Moderna says its vaccine is safe for babies, and travelers won't need COVID tests

Friday, June 10, 2022

Food and Drug Administration has released Moderna's data supporting the company's claim that its pediatric vaccines appear to be safe and effective, including for children as young as six months old.

Comment

Moderna says its new COVID vaccine is effective against omicron

Wednesday, June 08, 2022

Moderna says a new version of the company's COVID-19 vaccine appears to be highly effective against the omicron variant.

Comment

A new version of Moderna's COVID vaccine provides strong protection against Omicron

Wednesday, June 08, 2022

Moderna saysa new version of its COVID-19 vaccine appears to provide strong protection against the omicron variant as well as the original viral strain.

Comment

Moderna says its new vaccine booster shows 'superior' response to Omicron

Wednesday, June 08, 2022

The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate for an effective booster this fall. If the data pan out, it could lead to a yearly booster.

Comment

FDA advisors recommend the Novavax COVID vaccine

Wednesday, June 08, 2022

The Food and Drug Administration advisory committee recommends the agency authorize another COVID-19 vaccine in the hopes it might entice more people to get vaccinated.

Comment

Advisers to the FDA back Novavax COVID vaccine

Tuesday, June 07, 2022

Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.

Comment

A new COVID-19 vaccine may be on the way

Saturday, June 04, 2022

FDA scientists say another COVID-19 vaccine appears to be highly effective, potentially offering a new tool to entice the millions of people who still aren't vaccinated to finally get inoculated.

Comment

A new, more traditional COVID shot may appeal to those hesitant to get mRNA vaccines

Friday, June 03, 2022

FDA scientists have concluded that a new COVID vaccine — that could appeal to some vaccine-hesitant people — appears to be safe and effective, which means it may soon win authorization.

Comment

Novavax's COVID vaccine nears the finish line

Friday, June 03, 2022

The Novavax vaccine appears to be about 90% effective at preventing mild, moderate and severe COVID-19, Food and Drug Administration scientists say in an analysis of the company's data.

Comment

The White House says COVID vaccination for kids younger than 5 could start soon

Friday, June 03, 2022

The White House says babies, toddlers and other very young children could finally start getting vaccinated against COVID-19 as soon as June 21.

Comment

White House says COVID vaccination for kids younger than 5 could start in a few weeks

Thursday, June 02, 2022

COVID-19 vaccinations for children younger than 5 could start right after the Juneteenth holiday.

Comment

What's ailing long COVID patients? A new federal study looks for clues

Tuesday, May 24, 2022

The first results from an in-depth investigation of long COVID produced provocative results. Researchers don't understand the mechanism behind the lingering symptoms but found a link with anxiety.

Comment

A new federal study is trying to solve some of the mysterious about long-COVID

Monday, May 23, 2022

A detailed study of long-COVID patients fails to find any obvious physical explanation for their lingering health problems. The findings underscore the need for doctors to go beyond routine tests.

Comment

Low-dose COVID vaccine is safe and effective for young kids and babies, Pfizer says

Monday, May 23, 2022

Pfizer and BioNTech say three shots of their low-dose pediatric COVID vaccine appears to safely stimulate the immune systems of babies, toddlers and young children to protect them against omicron.

Comment

Pfizer says children under 5 can get 3 low-dose versions of its COVID-19 vaccine

Monday, May 23, 2022

Three shots of the Pfizer-BioNTech COVID-19 vaccines for kids 6 months to under 5 prompted a strong immune response. Preliminary data suggests the vaccine is effective and safe.

Comment

Another COVID surge strikes but vaccines are protecting people from the worst

Friday, May 20, 2022

An even more contagious omicron subvariant is fueling yet another surge of infections in the U.S. The number of hospitalizations is growing.

Comment

In wave after deadly wave, COVID has claimed 1 million lives in the U.S.

Tuesday, May 17, 2022

The virus became the third leading cause of death in the U.S., and caused so many to die in the prime of life that the country experienced the biggest drop in life expectancy since World War II.

Comment

FDA authorizes first COVID booster for children ages 5 to 11

Tuesday, May 17, 2022

The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot.

Comment

Almost 1 million Americans have died from COVID-19

Saturday, May 14, 2022

As the U.S. approaches 1 million COVID-19 deaths, cases and hospitalizations have started rising again, deaths are poised to creep up again, and the nation is on alert for yet another surge.

Comment